ArticleBritish journal of pharmacology2020

Targeting IL-5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab.

Luigino Calzetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.